汉语拼音名:Dengzhan Shengmai Jiaonang批件号:2002ZD-0987类别:地标升国标剂型:胶囊剂规格:每粒装0.18g生产单位:云南生物谷灯盏花药业有限公司国药准字:Z20026439实施规定 本标准自2002年12月1日起实施,同品种原地方标准、包装、标签和说明书同时停止使用。实施日前已上市的药品流通和使用至2003年6月30日,可仍按...
The results first confirmed the therapeutic effects of Dengzhan Shengmai against cognitive defects; specifically, Dengzhan Shengmai improved learning and impairment, suppressed neuro loss, and increased Nissl body morphology repair. Comprehensive integrated transcriptomics and microbiota analysis indicated that...
1.Objective: To observe the exact effectiveness of the treatment of chronic renal failure patients with Yunnan Deng Zhan Hua capsule.目的:观察云南灯盏花胶囊治疗慢性功能衰竭(CRF)的疗效。 4)Dengzhan Shengmai Granules灯盏生脉颗粒 1.Study on extraction technology for Dengzhan Shengmai Granules by ortho...
Chinese herbal medicine is widely used in treating stroke, for example, Dengzhan shengmai (DZSM) capsule. The current systematic review aims to comprehensively evaluate the efficacy and safety of the DZSM capsule in treating ischemic stroke. Materials and methods Eligible randomized controlled trials ...
2) "Dengzhan Shengmai Tablet" 灯盏生脉片 1. Determination of Scutellarin in "Dengzhan Shengmai Tablet" by RP-HPLC; HPLC法测定灯盏生脉片中野黄芩苷的含量3) Yunnan Deng Zhan Hua capsule 云南灯盏花胶囊 1. Objective: To observe the exact effectiveness of the treatment of chronic renal ...
灯盏生脉胶囊(生物谷),灯盏生脉胶囊,灯盏生脉胶囊(生物谷)价格,灯盏生脉胶囊(生物谷)功效,云南生物谷药业股份有限公司,功效:益气养阴,活血健脑。用于气阴两虚、瘀阻脑络引起的胸痹心痛,中风后遗症,症见痴呆、健忘、手足麻木症,冠心病心绞痛,缺血性心脑血管疾病,高脂
主治气明两虚、瘀阻脑络引起的胸痹心痛,中风后遗症,症见痴呆、健忘、手足麻木症,冠心病心绞痛,缺血性心脑血管疾病,高脂血症见上述证候者。 灯盏生脉胶囊用量用法 性状:本品为硬胶囊,内容物为灰褐色至棕褐色的粉末;味微苦。 规格:每粒装0.18克。 贮藏:密封。 用法用量:口服。一次2粒,一日3次,饭后30分钟服...
HEART failureRATSHEART diseasesHeart failure (HF) is an advanced stage of most heart diseases. Some studies reported that Dengzhanshengmai (DZSM) capsule may improve HF, but its mechanisms are unclear. This study attempts to determine the function of DZSM in treating HF and investi...
Clinical studies of the effect of a Dengzhan Shengmai capsules onnon-arteritic ischemic optic neuropathyZHU ChengyiYI QiongMA JinliWEI Qiping
Dengzhan shengmaiIschemic strokeRandomized controlled trialsSystematic reviewMeta-analysisObjective: The existing eligible randomized controlled trials (RCTs) were critically appraised for the effectiveness and safety of Chinese herbal medicine Dengzhan Shemnai for ischemic stroke.Yang, Xiao-YingWang, Li-...